Thermo Fisher Scientific (TMO) Competitors $480.84 +8.20 (+1.73%) Closing price 09/18/2025 03:59 PM EasternExtended Trading$479.88 -0.96 (-0.20%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), QIAGEN (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson QIAGEN West Pharmaceutical Services Mettler-Toledo International Waters Thermo Fisher Scientific (NYSE:TMO) and Medpace (NASDAQ:MEDP) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability. Do analysts recommend TMO or MEDP? Thermo Fisher Scientific currently has a consensus price target of $592.24, indicating a potential upside of 23.17%. Medpace has a consensus price target of $422.27, indicating a potential downside of 15.87%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, research analysts plainly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 5 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.77Medpace 3 Sell rating(s) 11 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.94 Is TMO or MEDP more profitable? Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.24% 16.82% 8.38% Medpace 18.74%67.66%21.86% Does the media prefer TMO or MEDP? In the previous week, Thermo Fisher Scientific had 44 more articles in the media than Medpace. MarketBeat recorded 66 mentions for Thermo Fisher Scientific and 22 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.32 beat Medpace's score of 1.20 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 55 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 15 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, TMO or MEDP? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B4.23$6.34B$17.2927.81Medpace$2.11B6.69$404.39M$13.4537.32 Do institutionals & insiders believe in TMO or MEDP? 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Comparatively, 20.3% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, TMO or MEDP? Thermo Fisher Scientific has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. SummaryThermo Fisher Scientific beats Medpace on 9 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$178.47B$6.81B$5.78B$21.57BDividend Yield0.36%1.20%5.74%3.50%P/E Ratio27.8127.0876.4830.17Price / Sales4.23198.95536.5477.21Price / Cash15.7421.6337.1724.62Price / Book3.715.0313.754.58Net Income$6.34B$178.07M$3.29B$1.00B7 Day Performance0.28%6.12%1.57%1.52%1 Month Performance-3.43%10.32%6.83%5.96%1 Year Performance-22.48%18.44%80.77%14.24% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.9689 of 5 stars$480.84+1.7%$592.24+23.2%-21.2%$178.47B$42.88B27.81125,000Positive NewsMEDPMedpace4.332 of 5 stars$496.95+1.3%$422.27-15.0%+38.9%$13.97B$2.11B36.975,900Positive NewsAAgilent Technologies4.5349 of 5 stars$125.78+2.1%$140.08+11.4%-8.2%$35.69B$6.51B29.5517,900Dividend AnnouncementAMNAMN Healthcare Services4.3567 of 5 stars$18.18-0.4%$23.25+27.9%-58.9%$697.81M$2.98B-2.342,968Positive NewsShort Interest ↓DHRDanaher4.9901 of 5 stars$188.18-1.0%$246.35+30.9%-28.2%$134.92B$23.88B40.0963,000Positive NewsHAEHaemonetics4.9463 of 5 stars$51.07-2.2%$78.78+54.3%-32.3%$2.46B$1.35B15.623,023Positive NewsMCKMcKesson4.6483 of 5 stars$703.29-1.1%$725.10+3.1%+34.9%$87.55B$359.05B28.0745,000Positive NewsQGENQIAGEN4.4768 of 5 stars$45.42+0.3%$49.69+9.4%+3.0%$10.10B$1.98B26.855,765Positive NewsWSTWest Pharmaceutical Services4.9936 of 5 stars$257.61+1.6%$319.50+24.0%-17.5%$18.54B$2.89B38.5910,600Positive NewsMTDMettler-Toledo International4.1176 of 5 stars$1,263.37+0.3%$1,311.11+3.8%-8.1%$26.10B$3.87B32.0817,300Positive NewsWATWaters4.7747 of 5 stars$299.06+1.2%$378.73+26.6%-7.9%$17.81B$3.05B26.977,600 Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives QIAGEN Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMO Stock Alerts